Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DJ-1/PARK7 mRNA is the transcript of the Parkinson disease protein 7 (PARK7) gene, which encodes the multifunctional protein deglycase DJ-1 [1, 2]. DJ-1 serves as a critical sensor and protector against oxidative stress, functioning as a redox-dependent chaperone and antioxidant that maintains mitochondrial integrity [1, 3]. In neurobiology, loss-of-function mutations in the PARK7 gene are a recognized cause of early-onset autosomal recessive Parkinson's disease, positioning the mRNA as a target for restoration therapies like mRNA replacement or stabilization [3, 5]. Conversely, DJ-1 is frequently overexpressed in various malignancies, where it acts as an oncogene by promoting cell survival, proliferation, and resistance to chemotherapy-induced apoptosis [4]. Consequently, therapeutic strategies targeting the PARK7 mRNA include the use of antisense oligonucleotides (ASOs) or RNA interference (RNAi) to either knockdown its expression in cancer or potentially modulate its levels in neurodegenerative conditions [5]. The dual role of DJ-1 as both a neuroprotective agent and an oncogene presents a significant challenge for therapeutic development, requiring precise control over its expression levels [4, 5].
Antisense inhibition, RNA interference-mediated degradation, and mRNA-based protein restoration [5]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parkinson disease protein 7 mRNA (PARK7 mRNA) (PARK7 mRNA).